Skip to content

Achieve Life Sciences ACHV Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$182K+98.5%
NGL Energy Partners logo
NGL Energy PartnersNGL
$4.42M+218%
Ryan Specialty Holdings logo
Ryan Specialty HoldingsRYAN
$27.29M+294%
OraSure Technologies logo
OraSure TechnologiesOSUR
$93K-80.5%
Shift4 Payments logo
Shift4 PaymentsFOUR
$0+100%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$2.39M-68.8%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1?
Achieve Life Sciences (ACHV) reported business combination contingent consideration arrangements change in amount of contingent consideration liability1 of -$285K in Q1 2026.
How has Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1 changed year-over-year?
Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1 decreased by 413.2% year-over-year, from $91K to -$285K.
What is the long-term trend for Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1?
Over 2 years (2023 to 2025), Achieve Life Sciences's business combination contingent consideration arrangements change in amount of contingent consideration liability1 has grown at a -12.1% compound annual growth rate (CAGR), from $528K to $408K.
What does business combination contingent consideration arrangements change in amount of contingent consideration liability1 mean?
The change in the fair value of liabilities related to potential future payments for business acquisitions. This reflects adjustments based on the probability of achieving specific performance milestones or financial targets. It provides insight into the financial impact of past M&A activity and potential future obligations.